12:00 AM
 | 
Feb 03, 2014
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Arcturus Therapeutics preclinical data

In non-human primates, a single 0.3 mg/kg IV dose of Arcturus' RNAi therapeutic targeting the TTR gene delivered using LUNAR technology led to...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >